This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Trade & Channel Strategies
See you in 2023! Stay tuned for dates and announcements!
December 12-14, 2023Philadelphia, PA

Erik Halstrom
Managing Director at Turning Point Rx


Turning Point Rx is an member owned organization comprised of the top independent, high performing, carefully vetted specialty pharmacies. Our member pharmacies include: Amber Pharmacy, Maxor Pharmacies, Senderra, CareMed, Meijer Specialty Pharmacy, BioPlus, Bluesky, Ardon, Total Care RX, Lumicera and Omnicell Pharmacy Servicess

Prior to joining Turning Point, Erik led the Specialty Division of MHA, a diversified healthcare and technology company. Erik was the vice president of corporate business development for FFF Enterprises a diversified healthcare company. Erik started his career in the pharmaceutical industry where he held leadership roles with Eli Lilly and Merck in the areas of sales, in-line and new product marketing, market access, PBM and Managed Care corporate accounts, strategic planning, and the creation of new distribution models.

Erik is a Board member and member of the Executive Committee of the National Association of Specialty Pharmacy (NASP) and is an acting Officer and Secretary of the Board. He is an editorial board member for Specialty Pharmacy Times, and an advisor to Vizient Inc.

Erik holds a Bachelor of Science in Business Management from St. John’s University, Minnesota, and a Masters in Business Administration from St. Joseph’s University, Philadelphia.

Agenda Sessions

  • Accelerating Complexities in Healthcare and the Delivery of Specialized Solutions


Speakers at this event